Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| M-Xylene SCHEMBL909803 | 0.97 | ACHE (0.67) | ACHEALDH1A1MAPK1CYP1A2CYP3A4 | |
| M-Xylene SCHEMBL28034890 | 0.89 | ACHE (0.63) | ACHEALDH1A1MAPK1CYP1A2CYP3A4 | |
| M-Xylene SCHEMBL2813350 | 0.87 | — | — | |
| M-Xylene SCHEMBL6397624 | 0.84 | — | — | |
| M-Xylene SCHEMBL891494 | 0.84 | ACHE (1.00) | ACHEALDH1A1MAPK1CYP1A2CYP3A4 | |
| M-Xylene SCHEMBL28189 | 0.84 | — | — | |
| SCHEMBL19260368 | 0.81 | ACHE (0.85) | ACHEALDH1A1MAPK1CYP1A2CYP3A4 | |
| M-Xylene SCHEMBL358508 | 0.81 | — | — | |
| M-Xylene SCHEMBL6772614 | 0.81 | — | — | |
| M-Xylene SCHEMBL18890231 | 0.81 | ACHE (0.92) | ACHEALDH1A1MAPK1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042791-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-12 | — | — | US | disclosed |
| US-12281129-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-04-22 | — | — | US | disclosed |
| US-11737349-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-22 | — | — | US | disclosed |
| US-20220402953-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSITY DISPLAY CORPORATION (US) | 2022-12-22 | — | — | US | disclosed |
| EP-3750897-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2020-12-16 | — | — | EP | disclosed |
| CN-112062788-A | Organic electroluminescent material and device | 环球展览公司 | 2020-12-11 | — | — | CN | disclosed |
| US-20200295277-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-09-17 | — | — | US | disclosed |
| US-9908819-B1 | Printing method for production a ceramic green body | WZR ceramic solutions GmbH (DE) | 2018-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281129-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OSBP | ACHE 803/4885ALDH1A1 134/4885MAPK1 1948/4885 |
| US-11737349-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OTC | ACHE 377/4885ALDH1A1 402/4885MAPK1 4372/4885 |
| US-20260042791-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRA1, MSL1 | ACHE 3763/4885ALDH1A1 1669/4885MAPK1 1097/4885 |
| US-20220402953-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | ACHE 803/4885ALDH1A1 134/4885MAPK1 1948/4885 |
| US-20200295277-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OTC | ACHE 377/4885ALDH1A1 402/4885MAPK1 4372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.